February 6, 2026, 6:45pm EST
A pharmacist and a physician team walk into a bar...
… and discuss how “The FDA’s weak drug manufacturing oversight is a potentially deadly problem”.
Related posts
In response to a request from APC and NCPA, FDA’s Center for Veterinary Medicine last week issued a...
The Alliance for Pharmacy Compounding is reviewing the FDA’s proposed rule addressing the 503B...